ETBI — Eastgate Biotech Balance Sheet
0.000.00%
HealthcareHighly SpeculativeMicro Cap
- $2.15m
- $5.23m
Annual balance sheet for Eastgate Biotech, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2012 December 31st | 2013 December 31st | 2014 December 31st | 2015 December 31st | 2016 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Short Term Investments | 0.1 | 0 | 0.286 | 0.019 | 0 |
| Net Total Receivables | — | — | 0.053 | 0.08 | 0 |
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 0.104 | 0 | 0.34 | 0.114 | 0 |
| Net Property, Plant And Equipment | — | 0.071 | 0.143 | 0.184 | 0 |
| Total Assets | 0.104 | 0.072 | 0.483 | 0.298 | 0 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 0.714 | 2.4 | 1.88 | 2.73 | 4.58 |
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Liabilities | 0.714 | 2.4 | 1.88 | 2.78 | 4.62 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | -0.609 | -2.33 | -1.4 | -2.48 | -4.62 |
| Total Liabilities & Shareholders' Equity | 0.104 | 0.072 | 0.483 | 0.298 | 0 |
| Total Common Shares Outstanding |